top of page
Editorial
Search
Innovent Announces the First Patient Dosed in the Phase 1 Study of IBI321 (Anti-PD-1/TIGIT Bispecifi
Jul 26, 20214 min read
Â
Â
Â


Suvoda wraps up first half of 2021 with strong business growth, geographical expansion, and new prod
Jul 26, 20212 min read
Â
Â
Â


Jul 26, 20213 min read
Â
Â
Â


Jul 26, 20212 min read
Â
Â
Â
Jul 26, 20212 min read
Â
Â
Â
Jul 26, 20211 min read
Â
Â
Â
Jul 26, 20212 min read
Â
Â
Â
Jul 26, 20212 min read
Â
Â
Â


Jul 26, 20215 min read
Â
Â
Â
Jul 26, 20212 min read
Â
Â
Â
Jul 26, 20212 min read
Â
Â
Â
Jul 26, 20213 min read
Â
Â
Â
Jul 26, 20215 min read
Â
Â
Â
Jul 26, 20211 min read
Â
Â
Â
Jul 26, 20212 min read
Â
Â
Â
Jul 26, 20211 min read
Â
Â
Â
Jul 26, 20211 min read
Â
Â
Â
Jul 26, 20212 min read
Â
Â
Â
Jul 25, 20211 min read
Â
Â
Â


Jul 25, 20211 min read
Â
Â
Â
Jul 25, 20211 min read
Â
Â
Â


Jul 25, 20211 min read
Â
Â
Â
Jul 25, 20211 min read
Â
Â
Â


Jul 25, 20213 min read
Â
Â
Â
bottom of page